These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8809227)

  • 21. 5-HT2B receptor-mediated calcium release from ryanodine-sensitive intracellular stores in human pulmonary artery endothelial cells.
    Ullmer C; Boddeke HG; Schmuck K; Lübbert H
    Br J Pharmacol; 1996 Mar; 117(6):1081-8. PubMed ID: 8882600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic organisation and functional expression of the gene encoding the human serotonin 5-HT2C receptor.
    Stam NJ; Vanderheyden P; van Alebeek C; Klomp J; de Boer T; van Delft AM; Olijve W
    Eur J Pharmacol; 1994 Nov; 269(3):339-48. PubMed ID: 7895773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant human serotonin 5A receptors stably expressed in C6 glioma cells couple to multiple signal transduction pathways.
    Noda M; Yasuda S; Okada M; Higashida H; Shimada A; Iwata N; Ozaki N; Nishikawa K; Shirasawa S; Uchida M; Aoki S; Wada K
    J Neurochem; 2003 Jan; 84(2):222-32. PubMed ID: 12558985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological characterisation of human 5-HT2 receptor subtypes.
    Jerman JC; Brough SJ; Gager T; Wood M; Coldwell MC; Smart D; Middlemiss DN
    Eur J Pharmacol; 2001 Feb; 414(1):23-30. PubMed ID: 11230991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterologous desensitization is evoked by both agonist and antagonist stimulation of the human 5-HT(7) serotonin receptor.
    Krobert KA; Andressen KW; Levy FO
    Eur J Pharmacol; 2006 Feb; 532(1-2):1-10. PubMed ID: 16487959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
    Labrecque J; Fargin A; Bouvier M; Chidiac P; Dennis M
    Mol Pharmacol; 1995 Jul; 48(1):150-9. PubMed ID: 7623769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: evidence favoring the ternary complex and two-state models of agonist action.
    Fitzgerald LW; Conklin DS; Krause CM; Marshall AP; Patterson JP; Tran DP; Iyer G; Kostich WA; Largent BL; Hartig PR
    J Neurochem; 1999 May; 72(5):2127-34. PubMed ID: 10217294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterisation of a 5-HT2 receptor cDNA cloned from Lymnaea stagnalis.
    Gerhardt CC; Leysen JE; Planta RJ; Vreugdenhil E; Van Heerikhuizen H
    Eur J Pharmacol; 1996 Sep; 311(2-3):249-58. PubMed ID: 8891606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activating mutations of the serotonin 5-HT2C receptor.
    Herrick-Davis K; Egan C; Teitler M
    J Neurochem; 1997 Sep; 69(3):1138-44. PubMed ID: 9282936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A unique phenotype of 5-HT2C, agonist-induced GTPgamma35S binding, transferable to 5-HT2A and 5-HT2B, upon swapping intracellular regions.
    Alberts GL; Chio CL; Im WB; Slightom JL
    Br J Pharmacol; 2003 Feb; 138(3):427-34. PubMed ID: 12569067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors.
    Bonhaus DW; Bach C; DeSouza A; Salazar FH; Matsuoka BD; Zuppan P; Chan HW; Eglen RM
    Br J Pharmacol; 1995 Jun; 115(4):622-8. PubMed ID: 7582481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid desensitization of serotonin 5-HT2C receptor-stimulated intracellular calcium mobilization in CHO cells transfected with cloned human 5-HT2C receptors.
    Akiyoshi J; Nishizono A; Yamada K; Nagayama H; Mifune K; Fujii I
    J Neurochem; 1995 Jun; 64(6):2473-9. PubMed ID: 7760026
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mianserin-induced down-regulation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors stably expressed in the human neuroblastoma cell line SH-SY5Y.
    Newton RA; Elliott JM
    J Neurochem; 1997 Sep; 69(3):1031-8. PubMed ID: 9282925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
    Dumuis A; Sebben M; Bockaert J
    Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
    Herrick-Davis K; Grinde E; Harrigan TJ; Mazurkiewicz JE
    J Biol Chem; 2005 Dec; 280(48):40144-51. PubMed ID: 16195233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin-2 (5-HT2) receptor-mediated signal transduction in human ciliary muscle cells: role in ocular hypotension.
    Sharif NA; Kelly CR; Crider JY; Davis TL
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):389-401. PubMed ID: 17238805
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.
    Westphal RS; Sanders-Bush E
    Mol Pharmacol; 1994 Nov; 46(5):937-42. PubMed ID: 7969083
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells.
    Thomas EA; Matli JR; Hu JL; Carson MJ; Sutcliffe JG
    J Neurosci Res; 2000 Jul; 61(1):75-81. PubMed ID: 10861802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transfection of human 5-hydroxytryptamine1A receptors in NIH-3T3 fibroblasts: effects of increasing receptor density on the coupling of 5-hydroxytryptamine1A receptors to adenylyl cyclase.
    Varrault A; Journot L; Audigier Y; Bockaert J
    Mol Pharmacol; 1992 Jun; 41(6):999-1007. PubMed ID: 1614416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in rapid desensitization of 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptor-mediated phospholipase C activation.
    Berg KA; Stout BD; Maayani S; Clarke WP
    J Pharmacol Exp Ther; 2001 Nov; 299(2):593-602. PubMed ID: 11602671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.